HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave. HIV ...

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However ...

UNAIDS is releasing a new report with the latest data on HIV following major disruptions in 2025, days ahead of the UN General Assembly High-Level Meeting on HIV/AIDS (22-23 June) when UN Member ...

Antiretroviral therapy (ART) has enabled most people living with HIV to live long and healthy lives. However, a small portion of people experience detectable traces of the virus, known as ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3 ...

Research strongly suggests that most persistent cases of viral detection after drug therapy are due to defective copies of ...

Each time LaTonya looks at framed photos of herself breastfeeding her baby son for the first time, she swells with emotion. As a mother living with HIV in Colorado, it was a moment she wanted to ...

Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus ...

By championing the simple phrase “Ask for an HIV Test,” experts with the Rutgers School of Nursing’s François-Xavier Bagnoud ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the ...

Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in ...